GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » PB Ratio

Entheon Biomedical (XCNQ:ENBI) PB Ratio : 3.66 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), Entheon Biomedical's share price is C$0.15. Entheon Biomedical's Book Value per Share for the quarter that ended in Feb. 2024 was C$0.04. Hence, Entheon Biomedical's PB Ratio of today is 3.66.

The historical rank and industry rank for Entheon Biomedical's PB Ratio or its related term are showing as below:

XCNQ:ENBI' s PB Ratio Range Over the Past 10 Years
Min: 0.18   Med: 1.89   Max: 5.24
Current: 3.66

During the past 7 years, Entheon Biomedical's highest PB Ratio was 5.24. The lowest was 0.18. And the median was 1.89.

XCNQ:ENBI's PB Ratio is ranked worse than
69.02% of 1320 companies
in the Biotechnology industry
Industry Median: 2.52 vs XCNQ:ENBI: 3.66

During the past 12 months, Entheon Biomedical's average Book Value Per Share Growth Rate was -53.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -73.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -51.00% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Entheon Biomedical was 198.10% per year. The lowest was -73.40% per year. And the median was -24.60% per year.

Back to Basics: PB Ratio


Entheon Biomedical PB Ratio Historical Data

The historical data trend for Entheon Biomedical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical PB Ratio Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
PB Ratio
Get a 7-Day Free Trial 1.25 0.91 3.52 2.88 1.89

Entheon Biomedical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.41 4.27 3.79 1.89 2.44

Competitive Comparison of Entheon Biomedical's PB Ratio

For the Biotechnology subindustry, Entheon Biomedical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's PB Ratio falls into.



Entheon Biomedical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Entheon Biomedical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Feb. 2024)
=0.15/0.041
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Entheon Biomedical  (XCNQ:ENBI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Entheon Biomedical PB Ratio Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines